FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Micro Considerations for Non-sterile Drugs

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Microbiological Quality Considerations in Non-Sterile Drug ...

2 FDA Gene Therapy Guidances Out

[ Price : $8.95]

FDA publishes one final and one draft guidance relating to gene therapy products.

FDA Clears Siemens NAEOTOM Alpha CT Device

[ Price : $8.95]

FDA clears the Siemens Medical Solutions NAEOTOM Alpha improved CT imaging device, described by the agency as the first major CT t...

CDER Drug Safety Staff Changes

[ Price : $8.95]

CDER drug safety operations (DSO) associate director Terry Toigo retires and, in the interim, DSO senior staff member Amy Ramanadh...

Appeals Court Reverses Catalyst Firdapse Loss to FDA

[ Price : $8.95]

The 11th Circuit Court of Appeals tells a Florida federal court it erred in granting summary judgment to FDA and Jacobus over orph...

Bipartisan Drug Supply Chain Bill Introduced

[ Price : $8.95]

Bills in the House and Senate would create an emergency supply of active pharmaceutical ingredients needed to make essential gener...

Apellis Plans NDA for Blindness Drug

[ Price : $8.95]

Apellis Pharmaceuticals says it will file an NDA for pegcetacoplan, an investigational, targeted C3 therapy treating geographic at...

Ex-CDER Official Laughren Retained by PharmaTher

[ Price : $8.95]

PharmaTher Holdings retains former CDER antipsychotic guru Thomas Laughren as a regulatory affairs advisor to help a depression th...

FDA Approves AbbVies Qulipta for Migraine Prevention

[ Price : $8.95]

FDA approves AbbVies novel migraine prevention drug Qulipta.

FDA Outmatched, Overwhelmed by Stem Cell Industry: Professor

[ Price : $8.95]

The Associated Press reports that FDA has been unsuccessful in asserting regulatory control over rapidly proliferating private ste...